empagliflozin vs semaglutide 2026 Update: is now an approved medication for cardiovascular diseases. It is recommended for the treatment of Type 2 diabetes and secondary prevention of cardiovascular complications in adults with established heart Two target trial emulation studies

In the SURPASS-3 trial, tirzepatide showed an 8.1% reduction in MRI-measured liver fat and AST, ALT and gamma-glutamyltransferase vs

The drugs also seem to reduce inflammation, which may help to reduce risk of cancer

While semaglutide does not directly alter these values significantly, a baseline CBC can identify anemia or other blood disorders that might complicate treatment

These guidelines are general and may not be suitable for every patient

Patients in Dallas who are overweight but do not suffer from diabetes, cancer, heart, liver or kidney problems, and do not have a history of medullary cancer of the thyroid type 2 are candidates for semaglutide therapy at North Texas Plastic Surgery